Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $60.6M | 0.05% |
801,500
+282,200
| +54% | +$20.5M |
|
327
Humana
HUM
$43.9B
| $60.5M | 0.05% |
243,996
+71,443
| +41% | +$17.6M |
|
328
Vertex Pharmaceuticals
VRTX
$121B
| $60.2M | 0.05% |
401,881
+134,325
| +50% | +$19.9M |
|
329
Regeneron Pharmaceuticals
REGN
$78.2B
| $60.2M | 0.05% |
160,013
-31,834
| -17% | -$12.9M |
|
330
PUT
NetEase
NTES
$83.3B
| $60.1M | 0.05% |
871,500
+124,000
| +17% | +$7.75M |
|
331
KKR & Co
KKR
$96.2B
| $60.1M | 0.05% |
2,851,851
+1,437,778
| +102% | +$28.9M |
|
332
PUT
Rio Tinto
RIO
$161B
| $59.9M | 0.05% |
1,130,800
-188,400
| -14% | -$9.2M |
|
333
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.87B
| $59.8M | 0.05% |
705,100
+400,400
| +131% | +$33.5M |
|
334
PUT
ExxonMobil
XOM
$639B
| $59.7M | 0.05% |
713,300
+63,800
| +10% | +$5.28M |
|
335
Western Digital
WDC
$190B
| $59.6M | 0.05% |
992,040
+267,843
| +37% | +$17.2M |
|
336
Phillips 66
PSX
$82.6B
| $59.1M | 0.05% |
584,527
+156,111
| +36% | +$14.8M |
|
337
Infosys
INFY
$50.1B
| $59M | 0.05% |
7,271,442
-1,058,540
| -13% | -$8.05M |
|
338
Automatic Data Processing
ADP
$106B
| $58.8M | 0.05% |
501,547
+284,918
| +132% | +$32.6M |
|
339
Consolidated Edison
ED
$39.9B
| $58.7M | 0.05% |
691,405
-5,431
| -0.8% | -$467K |
|
340
Stellantis
STLA
$21.9B
| $58.5M | 0.05% |
3,280,149
-199,422
| -6% | -$3.51M |
|
341
Northrop Grumman
NOC
$78.6B
| $58.4M | 0.05% |
190,386
+46,842
| +33% | +$14.1M |
|
|
K
342
DELISTED
Kellanova
K
| $58.1M | 0.05% |
910,585
+247,973
| +37% | +$14.9M |
|
343
PUT
United States Oil Fund
USO
$1.8B
| $58.1M | 0.05% |
604,388
+283,163
| +88% | +$25.1M |
|
344
PUT
United Airlines
UAL
$43.3B
| $58.1M | 0.05% |
861,300
+300,800
| +54% | +$18.8M |
|
345
Tyson Foods
TSN
$20.7B
| $58M | 0.05% |
715,138
+205,626
| +40% | +$15.7M |
|
|
SAGE
346
CALL
DELISTED
Sage Therapeutics
SAGE
| $57.8M | 0.05% |
350,900
+347,800
| +11,219% | +$33.7M |
|
347
PUT
Walmart Inc
WMT
$877B
| $57.7M | 0.05% |
1,754,400
-49,200
| -3% | -$1.51M |
|
|
GGP
348
DELISTED
GGP Inc.
GGP
| $57.7M | 0.05% |
2,465,978
+1,537,086
| +165% | +$34.2M |
|
349
PUT
Mondelez International
MDLZ
$78.8B
| $57.7M | 0.05% |
1,347,400
+196,100
| +17% | +$8.23M |
|
350
Estee Lauder
EL
$31.2B
| $57.5M | 0.05% |
452,028
+164,180
| +57% | +$19.7M |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.